应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CAI Caris Life Sciences, Inc.
休市中 12-05 16:00:00 EST
28.86
+0.54
+1.91%
盘后
28.77
-0.09
-0.31%
18:59 EST
最高
29.10
最低
27.47
成交量
291.36万
今开
28.21
昨收
28.32
日振幅
5.76%
总市值
81.43亿
流通市值
26.53亿
总股本
2.82亿
成交额
8,347万
换手率
3.17%
流通股本
9,192万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
CAI LIAN HE(蔡廉和)获批出任瑞泰人寿总经理
金融一线 · 12-05 18:01
CAI LIAN HE(蔡廉和)获批出任瑞泰人寿总经理
Caris Life Sciences, Inc.盘中异动 早盘股价大涨5.18%报27.40美元
市场透视 · 12-02
Caris Life Sciences, Inc.盘中异动 早盘股价大涨5.18%报27.40美元
本年度印度棉花产量或被高估
生意社 · 12-02
本年度印度棉花产量或被高估
中国新经济投资(00080)更名为“CAI控股”
智通财经 · 11-26
中国新经济投资(00080)更名为“CAI控股”
中国新经济投资(00080)采纳中文名称“CAI控股”作为新双重外文名称
智通财经 · 09-26
中国新经济投资(00080)采纳中文名称“CAI控股”作为新双重外文名称
Silver Lake二季度建仓Caris Life Sciences,清仓戴尔科技
DoNews · 08-09
Silver Lake二季度建仓Caris Life Sciences,清仓戴尔科技
中国金融租赁(02312)拟采用中文名称“CAI控股”作为新双重外文名称
智通财经 · 07-30
中国金融租赁(02312)拟采用中文名称“CAI控股”作为新双重外文名称
Caris Life Sciences, Inc.7月1日成交额为2335.98万美元
市场透视 · 07-02
Caris Life Sciences, Inc.7月1日成交额为2335.98万美元
Caris Life Sciences, Inc.6月30日成交额为2589.15万美元
市场透视 · 07-01
Caris Life Sciences, Inc.6月30日成交额为2589.15万美元
Caris Life Sciences, Inc.6月27日成交额为1426.11万美元
市场透视 · 06-28
Caris Life Sciences, Inc.6月27日成交额为1426.11万美元
Caris Life Sciences, Inc.6月26日成交额为1878.78万美元
市场透视 · 06-27
Caris Life Sciences, Inc.6月26日成交额为1878.78万美元
AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元 美股上市首日暴涨33%【招投洞策周报6月第4周】
药渡产业洞察 · 06-23
AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元 美股上市首日暴涨33%【招投洞策周报6月第4周】
AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元,美股上市首日暴涨33%
智通财经 · 06-19
AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元,美股上市首日暴涨33%
异动解读 | Caris Life Sciences(CAI)IPO首日盘中大涨28.57%,市值突破60亿美元
异动解读 · 06-19
异动解读 | Caris Life Sciences(CAI)IPO首日盘中大涨28.57%,市值突破60亿美元
异动解读 | 人工智能癌症诊断公司Caris Life Sciences上市首日盘中大涨28.57%
异动解读 · 06-19
异动解读 | 人工智能癌症诊断公司Caris Life Sciences上市首日盘中大涨28.57%
肿瘤AI诊断平台Caris(CAI.US)二次上调IPO发行价至21美元 市值有望达61亿美元
智通财经 · 06-18
肿瘤AI诊断平台Caris(CAI.US)二次上调IPO发行价至21美元 市值有望达61亿美元
AI精准肿瘤医学平台Caris Life Sciences(CAI.US)上调IPO规模 拟募资4.59亿美元
智通财经 · 06-17
AI精准肿瘤医学平台Caris Life Sciences(CAI.US)上调IPO规模 拟募资4.59亿美元
加载更多
公司概况
公司名称:
Caris Life Sciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立,并于2020年7月在德克萨斯州重新注册成立,总部位于德克萨斯州欧文。他们是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱。他们开发并商业化创新解决方案,通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健。他们的整个精准医疗解决方案组合旨在造福患者,最初的重点是肿瘤学,并服务于临床、学术和生物制药市场。
发行价格:
--
{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":28.86,"timestamp":1764968400000,"preClose":28.32,"halted":0,"volume":2913581,"hourTrading":{"tag":"盘后","latestPrice":28.77,"preClose":28.86,"latestTime":"18:59 EST","volume":13475,"amount":388755.72,"timestamp":1764979189056},"delay":0,"floatShares":91917486,"shares":282146923,"eps":-6.484615,"marketStatus":"休市中","change":0.54,"latestTime":"12-05 16:00:00 EST","open":28.21,"high":29.1,"low":27.47,"amount":83465643.351519,"amplitude":0.057556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.484615,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":28.32,"preHourTrading":{"tag":"盘前","latestPrice":28.37,"preClose":28.32,"latestTime":"09:26 EST","volume":812,"amount":22936.181548,"timestamp":1764944764064},"postHourTrading":{"tag":"盘后","latestPrice":28.77,"preClose":28.86,"latestTime":"18:59 EST","volume":13475,"amount":388755.72,"timestamp":1764979189056},"volumeRatio":0.702023,"impliedVol":0.846,"impliedVolPercentile":0.8376},"requestUrl":"/m/hq/s/CAI","defaultTab":"news","newsList":[{"id":"2589959518","title":"CAI LIAN HE(蔡廉和)获批出任瑞泰人寿总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2589959518","media":"金融一线","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589959518?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:01","pubTimestamp":1764928860,"startTime":"0","endTime":"0","summary":"12月5日金融一线消息,北京金融监管局发布批复,核准CAI LIAN HE(蔡廉和)瑞泰人寿保险有限公司总经理的任职资格。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:秦艺","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/hm/2025-12-05/doc-infztyka7668580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CAI","BK4104","BK4139","HE","BK4081"],"gpt_icon":0},{"id":"2588063407","title":"Caris Life Sciences, Inc.盘中异动 早盘股价大涨5.18%报27.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588063407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588063407?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:40","pubTimestamp":1764686411,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日22时40分,Caris Life Sciences, Inc.股票出现异动,股价大幅上涨5.18%。截至发稿,该股报27.40美元/股,成交量206.95万股,换手率0.73%,振幅6.72%。Caris Life Sciences, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Caris Life Sciences, Inc.公司简介:Caris Life Sciences Inc是一家以患者为中心的下一代人工智能技术生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512022240119526ec36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512022240119526ec36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAI","BK4139","BK4104"],"gpt_icon":0},{"id":"2588400063","title":"本年度印度棉花产量或被高估","url":"https://stock-news.laohu8.com/highlight/detail?id=2588400063","media":"生意社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588400063?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:52","pubTimestamp":1764636778,"startTime":"0","endTime":"0","summary":"USDA发布的11月报告显示,2025/26年度印度棉花产量预测为522.5万吨,与9月报告预测一致,与上年度产量持平;而印度棉花协会(CAI)发布2025/26年度棉花产量的首份预估显示,产量定为3050万包(折合518.5万吨),低于2024/25年度的74万包,同比下降2.37%。虽然二者预测相差4万吨,但已是近几年USDA与CAI对印度棉花产量预测的最小差距。印度旁遮普邦、古吉拉特邦等地私人轧花厂/棉商表示,CAI、USDA等机构对2025/26年度印度棉花产量的预测或仍有些偏高,后期或向下修正至510万吨以下。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202091807978ab0df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202091807978ab0df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4104","CAI"],"gpt_icon":0},{"id":"2586423255","title":"中国新经济投资(00080)更名为“CAI控股”","url":"https://stock-news.laohu8.com/highlight/detail?id=2586423255","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586423255?lang=zh_cn&edition=full","pubTime":"2025-11-26 18:50","pubTimestamp":1764154215,"startTime":"0","endTime":"0","summary":"香港公司注册处于2025年11月7日发出注册非香港公司更改名称注册证书,确认本公司的新英文名称“CAI Corp”及中文名称“CAI控股”分别根据香港法例第 622章公司条例第16部于香港注册登记。更改公司名称后,本公司英文股票简称将由“CNEWECON FUND”更改为“CAI CORP”及中文股票简称将由“中国新经济投资”更改为“CAI控股”,自2025年12月1日上午九时正起生效。本公司于联交所的股份代号维持不变,为“80”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","00080","BK1511","BK4104","CAI"],"gpt_icon":0},{"id":"2570019220","title":"中国新经济投资(00080)采纳中文名称“CAI控股”作为新双重外文名称","url":"https://stock-news.laohu8.com/highlight/detail?id=2570019220","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570019220?lang=zh_cn&edition=full","pubTime":"2025-09-26 18:00","pubTimestamp":1758880846,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国新经济投资(00080)发布公告,公司董事会建议将公司英文名称由“China New Economy Fund Limited”更改为“CAI Corp”及采纳中文名称“CAI控股”作为其新双重外文名称,以代替现有中文名称“中国新经济投资有限公司”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","CAI","BK4104","00080","BK1511"],"gpt_icon":0},{"id":"2558164504","title":"Silver Lake二季度建仓Caris Life Sciences,清仓戴尔科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2558164504","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558164504?lang=zh_cn&edition=full","pubTime":"2025-08-09 21:18","pubTimestamp":1754745481,"startTime":"0","endTime":"0","summary":"2025年8月9日,根据最新13F报告,Silver Lake Group LLC在二季度建仓做多Caris Life Sciences,并选择清仓戴尔科技。其重仓股还包括First Advantage、Global Blue Group Holding、Unity Software、EverCommerce和N-able。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080921192594d99712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080921192594d99712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1267930227.SGD","LU0976567544.SGD","DELL","BK4543","BK4139","BK4104","LU0128525689.USD","LU0496365809.HKD","BK4535","LU0211326839.USD","BK4588","BK4585","LU0267386448.USD","LU0052756011.USD","LU0310800965.SGD","BK4515","LU0211326755.USD","CAI","BK4170"],"gpt_icon":0},{"id":"2555662019","title":"中国金融租赁(02312)拟采用中文名称“CAI控股”作为新双重外文名称","url":"https://stock-news.laohu8.com/highlight/detail?id=2555662019","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555662019?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:44","pubTimestamp":1753865091,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国金融租赁(02312)发布公告,董事会建议将公司英文名称由“China Financial Leasing Group Limited”更改为“CAI Corp”,并采用中文名称“CAI控股”作为新双重外文名称,以取代其现有中文名称“中国金融租赁集团有限公司”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CAI","BK4104","BK1156","BK4139","02312","BK1511"],"gpt_icon":0},{"id":"2548832710","title":"Caris Life Sciences, Inc.7月1日成交额为2335.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832710?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:26","pubTimestamp":1751419598,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,Caris Life Sciences, Inc.成交额为2335.98万美元,成交额较昨日减少9.78%,当日成交量为88.47万股。Caris Life Sciences, Inc.于2025年7月1日跌0.79%,报26.51美元,该股过去5个交易日跌4.3%,年初至今涨26.24%,过去60日涨26.24%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-01|2335.98万|-9.78%|88.47万|#|2025-06-30|2589.15万|81.55%|97.28万|#|2025-06-27|1426.11万|-24.09%|53.60万|#|2025-06-26|1878.78万|-24.51%|69.93万|#|2025-06-25|2488.79万|-49.02%|93.46万|Caris Life Sciences Inc 是一家以患者为中心的下一代人工智能技术生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092645a4c9f209&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092645a4c9f209&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2548042205","title":"Caris Life Sciences, Inc.6月30日成交额为2589.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548042205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548042205?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:25","pubTimestamp":1751333116,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,Caris Life Sciences, Inc.成交额为2589.15万美元,成交额较昨日增加81.55%,当日成交量为97.28万股。Caris Life Sciences, Inc.于2025年6月30日跌0.34%,报26.72美元,该股过去5个交易日涨3.01%,年初至今涨27.24%,过去60日涨27.24%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-30|2589.15万|81.55%|97.28万|#|2025-06-27|1426.11万|-24.09%|53.60万|#|2025-06-26|1878.78万|-24.51%|69.93万|#|2025-06-25|2488.79万|-49.02%|93.46万|#|2025-06-24|4881.47万|-19.52%|176.71万|Caris Life Sciences Inc 是一家以患者为中心的下一代人工智能技术生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092524a4c7b295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701092524a4c7b295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2546778987","title":"Caris Life Sciences, Inc.6月27日成交额为1426.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546778987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546778987?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:26","pubTimestamp":1751073977,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,Caris Life Sciences, Inc.成交额为1426.11万美元,成交额较昨日减少24.09%,当日成交量为53.60万股。Caris Life Sciences, Inc.于2025年6月27日涨0.22%,报26.81美元,该股过去5个交易日跌1.61%,年初至今涨27.67%,过去60日涨27.67%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-27|1426.11万|-24.09%|53.60万|#|2025-06-26|1878.78万|-24.51%|69.93万|#|2025-06-25|2488.79万|-49.02%|93.46万|#|2025-06-24|4881.47万|-19.52%|176.71万|#|2025-06-23|6065.24万|-58.51%|230.29万|Caris Life Sciences Inc 是一家以患者为中心的下一代人工智能技术生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092620a721d814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092620a721d814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAI","BK4104"],"gpt_icon":0},{"id":"2546769659","title":"Caris Life Sciences, Inc.6月26日成交额为1878.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546769659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546769659?lang=zh_cn&edition=full","pubTime":"2025-06-27 09:26","pubTimestamp":1750987572,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日,Caris Life Sciences, Inc.成交额为1878.78万美元,成交额较昨日减少24.51%,当日成交量为69.93万股。Caris Life Sciences, Inc.于2025年6月26日涨1.21%,报26.75美元,该股过去5个交易日跌4.46%,年初至今涨27.38%,过去60日涨27.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-26|1878.78万|-24.51%|69.93万|#|2025-06-25|2488.79万|-49.02%|93.46万|#|2025-06-24|4881.47万|-19.52%|176.71万|#|2025-06-23|6065.24万|-58.51%|230.29万|#|2025-06-20|1.46亿|-65.09%|530.04万|Caris Life Sciences Inc 是一家以患者为中心的下一代人工智能技术生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627092617a4c0053b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627092617a4c0053b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAI","BK4139","BK4104"],"gpt_icon":1},{"id":"2545112134","title":"AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元 美股上市首日暴涨33%【招投洞策周报6月第4周】","url":"https://stock-news.laohu8.com/highlight/detail?id=2545112134","media":"药渡产业洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545112134?lang=zh_cn&edition=full","pubTime":"2025-06-23 20:23","pubTimestamp":1750681383,"startTime":"0","endTime":"0","summary":"一周投融资事件概述据药渡企业洞察统计,大健康领域共披露投融资事件49起,其中37起融资披露了融资金额和币种信息,总规模超125.21亿元人民币。按照金额划分:亿元及以上事件22起,最高金额来自医疗科技公司Caris Life Sciences,在美股首次公开募股中筹资4.94亿美元,发行价高于原定区间上限。该股一经上市便高涨至近40%。按照已披露的融资轮次:早期融资18起,中后期融资8起,战略融资6起,被收购2起,定向增发1起,IPO上市1起,未披露7起。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623202857a718ce43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623202857a718ce43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAI","BK4104","BK4139"],"gpt_icon":1},{"id":"2544189883","title":"AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元,美股上市首日暴涨33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544189883","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544189883?lang=zh_cn&edition=full","pubTime":"2025-06-19 08:29","pubTimestamp":1750292990,"startTime":"0","endTime":"0","summary":"医疗科技公司 $Caris Life Sciences, Inc.$ 于美东时间周三登陆纳斯达克市场,在美股首次公开募股中筹资4.94亿美元,发行价高于原定区间上限。由Sixth Street Partners支持的Caris以每股21美元定价发行2350万股,较最初19至20美元的定价区间再度上调。财务数据显示,2025年一季度Caris营收1.209亿美元,净亏损1.27亿美元;去年同期则是8070万美元营收和1.341亿美元亏损,亏损幅度收窄。招股书显示,上市后哈尔伯特将持股41.7%,Sixth Street Partners和私募公司JH Whitney Capital Partners的关联机构分别持股9.8%和6.8%。","market":"sh","thumbnail":"https://static.tigerbbs.com/e8b0f780677ea8775adba056c750411a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e8b0f780677ea8775adba056c750411a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d005a2f9a47d099d0e2bd1b2ead6e0c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307017.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AI精准肿瘤医学平台Caris Life Sciences筹资4.94亿美元,美股上市首日暴涨33%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4104","CAI"],"gpt_icon":1},{"id":"1162726850","title":"异动解读 | Caris Life Sciences(CAI)IPO首日盘中大涨28.57%,市值突破60亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162726850","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162726850?lang=zh_cn&edition=full","pubTime":"2025-06-19 00:28","pubTimestamp":1750264124,"startTime":"0","endTime":"0","summary":"专注于肿瘤学的人工智能分子诊断平台Caris Life Sciences今日在纳斯达克上市,盘中大涨28.57%,引发市场关注。Caris Life Sciences此次IPO定价为每股21美元,高于此前上调后的19至20美元区间,共发行2350万股股票,募资4.94亿美元。Caris Life Sciences是一家基于人工智能的精准医疗公司,通过下一代测序、人工智能和机器学习技术,开发用于治疗癌症的精准医学诊断解决方案。投资者对Caris Life Sciences在癌症诊断领域的创新技术和未来增长潜力表现出强烈兴趣,推动了股价的大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d005a2f9a47d099d0e2bd1b2ead6e0c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAI"],"gpt_icon":0},{"id":"1179646341","title":"异动解读 | 人工智能癌症诊断公司Caris Life Sciences上市首日盘中大涨28.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179646341","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179646341?lang=zh_cn&edition=full","pubTime":"2025-06-19 00:28","pubTimestamp":1750264112,"startTime":"0","endTime":"0","summary":"专注于肿瘤学的人工智能分子诊断平台Caris Life Sciences今日在纳斯达克市场首次亮相,盘中大涨28.57%,引起投资者广泛关注。Caris Life Sciences此前完成了4.94亿美元的首次公开募股,以每股21美元的价格发行了2350万股股票。按IPO价格计算,Caris Life Sciences的市值达到61亿美元,比最初预期高出17%。投资者对Caris Life Sciences的强烈兴趣反映了市场对人工智能在医疗领域应用的看好,特别是在癌症诊断和精准医疗方面。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d005a2f9a47d099d0e2bd1b2ead6e0c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAI"],"gpt_icon":0},{"id":"2544923794","title":"肿瘤AI诊断平台Caris(CAI.US)二次上调IPO发行价至21美元 市值有望达61亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544923794","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544923794?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:25","pubTimestamp":1750231544,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注于肿瘤学的人工智能分子诊断平台Caris Life Sciences以每股21美元的价格发行了2350万股股票,融资4.94亿美元,高于上调后的19至20美元区间。按定价计算,Caris完全稀释后的市值为61亿美元,比最初预期高出17%。Caris表示,其平台基于超过650万次测试的数据集,在超过84.9万例病例中运行,并产生了超过380亿个分子标记的测量结果。Caris生命科学计划在纳斯达克上市,股票代码为CAI。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306647.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"肿瘤AI诊断平台Caris(CAI.US)二次上调IPO发行价至21美元 市值有望达61亿美元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4104","CAI"],"gpt_icon":1},{"id":"2544958782","title":"AI精准肿瘤医学平台Caris Life Sciences(CAI.US)上调IPO规模 拟募资4.59亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544958782","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544958782?lang=zh_cn&edition=full","pubTime":"2025-06-17 15:02","pubTimestamp":1750143762,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一,专注于肿瘤分子诊断的人工智能平台Caris Life Sciences宣布上调其即将进行的首次公开募股的发行价区间。按修订后区间中值计算,Caris Life Sciences的募资额将比原预期高出15%。Caris Life Sciences表示,其平台基于超过84.9万例临床病例的650万次检测数据,已累计分析逾380亿个分子标记。Caris Life Sciences成立于2008年,在截至2025年3月31日的12个月内实现营收4.52亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI精准肿瘤医学平台Caris Life Sciences(CAI.US)上调IPO规模 拟募资4.59亿美元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CAI","BK4104"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":0.1304},{"period":"1month","weight":-0.012},{"period":"3month","weight":-0.1719},{"period":"6month","weight":0.3743},{"period":"ytd","weight":0.3743}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caris Life Sciences, Inc.于2011年11月根据开曼群岛法律注册成立,并于2020年7月在德克萨斯州重新注册成立,总部位于德克萨斯州欧文。他们是一家领先的、以患者为中心的下一代AI科技生物公司和精准医疗先驱。他们开发并商业化创新解决方案,通过大规模使用综合分子信息和人工智能/机器学习算法来改变医疗保健。他们的整个精准医疗解决方案组合旨在造福患者,最初的重点是肿瘤学,并服务于临床、学术和生物制药市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caris Life Sciences, Inc.(CAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caris Life Sciences, Inc.(CAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}